Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).
Identifieur interne : 001C41 ( Main/Corpus ); précédent : 001C40; suivant : 001C42Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).
Auteurs : P. Peretti-Watel ; B. Spire ; J. Pierret ; F. Lert ; Y. ObadiaSource :
- AIDS care [ 0954-0121 ] ; 2006.
English descriptors
- KwdEn :
- Adult (MeSH), Antiretroviral Therapy, Highly Active (psychology), Cross-Sectional Studies (MeSH), Family Relations (MeSH), Female (MeSH), France (MeSH), HIV Infections (drug therapy), HIV Infections (psychology), Humans (MeSH), Interpersonal Relations (MeSH), Male (MeSH), Middle Aged (MeSH), Patient Compliance (statistics & numerical data), Prejudice (MeSH), Self Disclosure (MeSH), Stereotyping (MeSH).
- MESH :
- geographic : France.
- drug therapy : HIV Infections.
- psychology : Antiretroviral Therapy, Highly Active, HIV Infections.
- statistics & numerical data : Patient Compliance.
- Adult, Cross-Sectional Studies, Family Relations, Female, Humans, Interpersonal Relations, Male, Middle Aged, Prejudice, Self Disclosure, Stereotyping.
Abstract
This study investigated patterns of HIV disclosure to significant others (parents, siblings, children, other relatives, friends and colleagues) and describe them in terms of socio-demographic background and other characteristics, including experiences of AIDS-related discrimination. It also assessed the relationship between disclosure patterns and adherence to HAART. We used a cross-sectional survey conducted among a national representative sample of 2,932 HIV-infected people recruited in French hospitals. HIV disclosure patterns were both selective and cumulative: disclosure was more frequent for friends and siblings, while concealment prevailed concerning children, other relatives, and colleagues; but patients who disclosed their seropositivity to one significant other were also more likely to disclose it to other significant others. Patients reporting experiences of discrimination from sexual partners were less likely to be highly adherent, and we also found a significant relationship between uncontrolled disclosure and non-adherence. Patients who have opted for concealment probably consider non-adherence and uncontrolled disclosure as competing risks, but among them a significant minority loses on both counts. Counselling provided to HIV-infected people should not separate the adherence and disclosure issues, and adherence interventions should seek to help patients to manage concurrently disclosure/concealment of their seropositivity and its consequences.
DOI: 10.1080/09540120500456193
PubMed: 16546787
Links to Exploration step
pubmed:16546787Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).</title><author><name sortKey="Peretti Watel, P" sort="Peretti Watel, P" uniqKey="Peretti Watel P" first="P" last="Peretti-Watel">P. Peretti-Watel</name><affiliation><nlm:affiliation>Regional Centre for Disease Control of South-Eastern France, Marseilles, France. peretti@marseille.inserm.fr</nlm:affiliation></affiliation></author><author><name sortKey="Spire, B" sort="Spire, B" uniqKey="Spire B" first="B" last="Spire">B. Spire</name></author><author><name sortKey="Pierret, J" sort="Pierret, J" uniqKey="Pierret J" first="J" last="Pierret">J. Pierret</name></author><author><name sortKey="Lert, F" sort="Lert, F" uniqKey="Lert F" first="F" last="Lert">F. Lert</name></author><author><name sortKey="Obadia, Y" sort="Obadia, Y" uniqKey="Obadia Y" first="Y" last="Obadia">Y. Obadia</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16546787</idno><idno type="pmid">16546787</idno><idno type="doi">10.1080/09540120500456193</idno><idno type="wicri:Area/Main/Corpus">001C41</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001C41</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).</title><author><name sortKey="Peretti Watel, P" sort="Peretti Watel, P" uniqKey="Peretti Watel P" first="P" last="Peretti-Watel">P. Peretti-Watel</name><affiliation><nlm:affiliation>Regional Centre for Disease Control of South-Eastern France, Marseilles, France. peretti@marseille.inserm.fr</nlm:affiliation></affiliation></author><author><name sortKey="Spire, B" sort="Spire, B" uniqKey="Spire B" first="B" last="Spire">B. Spire</name></author><author><name sortKey="Pierret, J" sort="Pierret, J" uniqKey="Pierret J" first="J" last="Pierret">J. Pierret</name></author><author><name sortKey="Lert, F" sort="Lert, F" uniqKey="Lert F" first="F" last="Lert">F. Lert</name></author><author><name sortKey="Obadia, Y" sort="Obadia, Y" uniqKey="Obadia Y" first="Y" last="Obadia">Y. Obadia</name></author></analytic><series><title level="j">AIDS care</title><idno type="ISSN">0954-0121</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Antiretroviral Therapy, Highly Active (psychology)</term><term>Cross-Sectional Studies (MeSH)</term><term>Family Relations (MeSH)</term><term>Female (MeSH)</term><term>France (MeSH)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (psychology)</term><term>Humans (MeSH)</term><term>Interpersonal Relations (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Patient Compliance (statistics & numerical data)</term><term>Prejudice (MeSH)</term><term>Self Disclosure (MeSH)</term><term>Stereotyping (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Compliance</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cross-Sectional Studies</term><term>Family Relations</term><term>Female</term><term>Humans</term><term>Interpersonal Relations</term><term>Male</term><term>Middle Aged</term><term>Prejudice</term><term>Self Disclosure</term><term>Stereotyping</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study investigated patterns of HIV disclosure to significant others (parents, siblings, children, other relatives, friends and colleagues) and describe them in terms of socio-demographic background and other characteristics, including experiences of AIDS-related discrimination. It also assessed the relationship between disclosure patterns and adherence to HAART. We used a cross-sectional survey conducted among a national representative sample of 2,932 HIV-infected people recruited in French hospitals. HIV disclosure patterns were both selective and cumulative: disclosure was more frequent for friends and siblings, while concealment prevailed concerning children, other relatives, and colleagues; but patients who disclosed their seropositivity to one significant other were also more likely to disclose it to other significant others. Patients reporting experiences of discrimination from sexual partners were less likely to be highly adherent, and we also found a significant relationship between uncontrolled disclosure and non-adherence. Patients who have opted for concealment probably consider non-adherence and uncontrolled disclosure as competing risks, but among them a significant minority loses on both counts. Counselling provided to HIV-infected people should not separate the adherence and disclosure issues, and adherence interventions should seek to help patients to manage concurrently disclosure/concealment of their seropositivity and its consequences.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16546787</PMID><DateCompleted><Year>2006</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0954-0121</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Apr</Month></PubDate></JournalIssue><Title>AIDS care</Title><ISOAbbreviation>AIDS Care</ISOAbbreviation></Journal><ArticleTitle>Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).</ArticleTitle><Pagination><MedlinePgn>254-61</MedlinePgn></Pagination><Abstract><AbstractText>This study investigated patterns of HIV disclosure to significant others (parents, siblings, children, other relatives, friends and colleagues) and describe them in terms of socio-demographic background and other characteristics, including experiences of AIDS-related discrimination. It also assessed the relationship between disclosure patterns and adherence to HAART. We used a cross-sectional survey conducted among a national representative sample of 2,932 HIV-infected people recruited in French hospitals. HIV disclosure patterns were both selective and cumulative: disclosure was more frequent for friends and siblings, while concealment prevailed concerning children, other relatives, and colleagues; but patients who disclosed their seropositivity to one significant other were also more likely to disclose it to other significant others. Patients reporting experiences of discrimination from sexual partners were less likely to be highly adherent, and we also found a significant relationship between uncontrolled disclosure and non-adherence. Patients who have opted for concealment probably consider non-adherence and uncontrolled disclosure as competing risks, but among them a significant minority loses on both counts. Counselling provided to HIV-infected people should not separate the adherence and disclosure issues, and adherence interventions should seek to help patients to manage concurrently disclosure/concealment of their seropositivity and its consequences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peretti-Watel</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Regional Centre for Disease Control of South-Eastern France, Marseilles, France. peretti@marseille.inserm.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spire</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Pierret</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lert</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Obadia</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><CollectiveName>VESPA Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>AIDS Care</MedlineTA><NlmUniqueID>8915313</NlmUniqueID><ISSNLinking>0954-0121</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005195" MajorTopicYN="N">Family Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011287" MajorTopicYN="N">Prejudice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012650" MajorTopicYN="Y">Self Disclosure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013240" MajorTopicYN="N">Stereotyping</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>3</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>8</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>3</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16546787</ArticleId><ArticleId IdType="pii">V012675865234K33</ArticleId><ArticleId IdType="doi">10.1080/09540120500456193</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001C41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:16546787
|texte= Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:16546787" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |